AbbVie
ABBV · NYSE
Bulios Fair Price
$229.44
13.9% downside
Trenutna cena
$266.4
Po podatkih Bulios Fair Price je delnica ABBV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
AbbVie (ABBV) is a global pharmaceutical company specializing in the development and manufacturing of innovative medicines. Their portfolio includes drugs in the areas of immunology, oncology, neuroscience, and other therapeutic areas. With strong research and development capabilities, AbbVie offers a promising investment opportunity for long-term focused investors in the healthcare sector. Add ABBV stock to your watchlist on Bulios and stay informed about the latest news and innovations in the pharmaceutical industry.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Michael
Employees
57,000
Headquarters
North Chicago
Prihajajoči dogodki
Ex-Dividend
Ex-dividend date
Earnings
Upcoming earnings report
Dividend Payment
Datum plačila